 comeback tuberculosi drug regimen prevent treatment tuberculosi increas recent year physician awar effect drug avail diseas pharmacokinet schedul advers reaction anti-tubercul agent need short cours therapi isoniazid rifampin rifadin rimactan pyrazinamid initi month isoniazid rifampin month drug resist factor fourth drug initi regimen therapi chemoprophylaxi isoniazid import incid tuberculosi high-risk person